Results 161 to 170 of about 290,996 (382)

Evaluation and comparison of inserting temporary transvenous pacemaker using blind method and 2dimentional echocardiographic guide in hospitalized patients in Ardabil Bu-Ali hospital during 1378-1384 [PDF]

Introduction: Temporary transvenous pacemakers are used in urgent management of patients with severe bradyarrythmia and unstable hemodynamic state and not responded to drug therapy.
امانی, فیروز, حسینیان, عدالت, دوستکامی, حسین, هژبری, سلیم   +3 more
core  

Forecasting heart failure: Seasonal alignment of heart failure outcomes in New York

ESC Heart Failure, Volume 12, Issue 2, Page 819-831, April 2025.
Abstract Background Seasonal variations have been observed in heart failure (HF) hospitalization. Numerous explanatory mechanisms have been proposed, but no prior studies have examined potential contributors directly. Our objective was to identify specific factors that could contribute to seasonal variability using a large longitudinal dataset of HF ...
Prerna Gupta, Ellen Brinza, Prateeti Khazanie, Pamela N. Peterson, P Michael Ho, David P. Kao   +5 more
wiley   +1 more source

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

ESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen, Aldina Pivodic, Maria Schaufelberger, Annika Rosengren, Michael Fu   +4 more
wiley   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Prognostic role of high‐sensitivity cardiac troponin T in patients with cardiac sarcoidosis: insights from ILLUMINATE‐CS

ESC Heart Failure, Volume 12, Issue 2, Page 869-878, April 2025.
Abstract Aims The prognostic role of high‐sensitivity cardiac troponin T (hs‐cTnT) as a biomarker in patients with cardiac sarcoidosis (CS) has yet to be fully determined, especially when compared with B‐type natriuretic peptide (BNP). Methods and Results In this post‐hoc analysis of the ILLUMINATE‐CS (ILLUstration of the Management and prognosIs of ...
Yuichi Baba, Toru Kubo, Takeru Nabeta, Yuya Matsue, Takeshi Kitai, Yoshihisa Naruse, Tatsunori Taniguchi, Hidekazu Tanaka, Takahiro Okumura, Kenji Yoshioka, Hiroaki Kitaoka   +10 more
wiley   +1 more source

Activity-Dependent Regulation of HCN Pacemaker Channels by Cyclic AMP [PDF]

, 2002
Jing Wang, Shan Chen, Matthew F. Nolan, Steven A. Siegelbaum   +3 more
openalex   +1 more source

Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator

New England Journal of Medicine, 2017
R. Russo, H. Costa, Patricia D. Silva, Jeffrey L. Anderson, A. Arshad, R. Biederman, N. Boyle, Jennifer V. Frabizzio, U. Birgersdotter-Green, S. Higgins, R. Lampert, Christian E. Machado, E. Martin, A. Rivard, Jason C. Rubenstein, R. Schaerf, Jennifer D. Schwartz, D. Shah, G. Tomassoni, G. Tominaga, A. Tonkin, S. Uretsky, S. Wolff   +22 more
semanticscholar   +1 more source

Left ventricular function improvement during angiotensin receptor–neprilysin inhibitor treatment in a cohort of HFrEF/HFmrEF patients

ESC Heart Failure, Volume 12, Issue 2, Page 1151-1165, April 2025.
Prediction of LVEF improvement in patients with HFrEF and HFmrEF following treatment with Sacubitril/Valsartan. Workflow of this study investigating the functional capacity improvement in response to Sacubitrail/Valsartsan in a real‐world scenario of heart failure treatment.
Florian Appenzeller, Tobias Harm, Manuel Sigle, Parwez Aidery, Klaus‐Peter Kreisselmeier, Livia Baas, Andreas Goldschmied, Meinrad Paul Gawaz, Karin Anne Lydia Müller   +8 more
wiley   +1 more source

Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry [PDF]

, 2016
Mauro Biffi, Matteo Bertini, Davide Saporito, Giuseppina Belotti, Fabio Quartieri, M Piancastelli, Angelo Pucci, Giulio Boggian, Gian Franco Mazzocca, Davide Giorgi, P Diotallevi, Igor Diemberger, Cristian Martignani, Stefano Pancaldi, Matteo Ziacchi, Lina Marcantoni, Tiziano Toselli, Simone Attala, Matteo Iori, Nicola Bottoni, Selina Argnani, Corrado Tomasi, Biagio Sassone, Giuseppe Boriani   +23 more
openalex   +1 more source

Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction

Circulation, 2003
M. Sweeney, A. Hellkamp, K. Ellenbogen, A. Greenspon, R. Freedman, Kerry L Lee, G. Lamas   +6 more
semanticscholar   +1 more source